AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MPH Health Care

Share Issue/Capital Change May 9, 2012

5425_rns_2012-05-09_baf8d801-6d9f-486b-8acf-1c517f9a42d8.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

News Details

Corporate | 9 May 2012 10:32

MPH Mittelständische Pharma Holding AG: MPH acquires 52 % of the share capital of Windsor AG

MPH Mittelständische Pharma Holding AG / Key word(s): Acquisition/Capital Increase

09.05.2012 / 10:32


Corporate News of the MPH Mittelständische Pharma Holding AG about the purchase of roughly 52% of the capital of the company WINDSOR AG

MPH Mittelständische Pharma Holding AG:

The company MPH AG announces the purchase of roughly 52% of the equity capital of the company WINDSOR AG, Berlin.

Berlin, May 9, 2012.

The company MPH Mittelständische Pharma Holding AG, Berlin (ISIN: DE000A0NF697), announces the purchase of roughly 52% of the equity capital of the company WINDSOR AG, Berlin (ISIN: DE0006190705). Roughly 2.2 mill. WINDSOR shares were purchased at the stock exchange or at market prices. A further 5 mill. WINDSOR shares were purchased through an increase in capital at the company MPH Mittelständische Pharma Holding AG. The increase in capital registered on May 7, 2012, at the Commercial Registry Berlin-Charlottenburg against an in kind capital contribution from EUR 38,050,000 of EUR 3,117,155 to EUR 41,167,155 from authorized capital through the emission of 3,117,155 new ordinary bearer shares, was completely subscribed by the company MAGNUM AG, Schönefeld.

Through the integration of the pharmaceutical activities of the company WINDSOR AG the MPH-Group obtains access to additional business areas, which are active in other pharmaceutical value creation phases. The development of these further activities is of strategic interest.

About the company MPH Mittelständische Pharma Holding AG:

The Berlin company MPH Mittelständische Pharma Holding AG has strategically concentrated its activities on growth segments in the pharmaceutical market. With pharmaceutical products based on patent-free and patent-protected active substances, which are made available through the MPH-Group in the therapeutic areas oncology, HIV, rheumatology, neurology and cardiovascular diseases, the corporate group contributes towards cost reduction in the healthcare sector.

The company MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) of the Frankfurt stock exchange.

Details about shares of MPH Mittelständische Pharma Holding AG:

Share capital: EUR 38,050,000

Quoted shares: bearer preference shares

Number of circulating preferred shares: 19,025,000

ISIN: DE000A0NF697

WKN: A0NF69

Ticker symbol: 93MV

Contact:

MPH Mittelständische Pharma Holding AG

Patricia Blechinger

Hubertusallee 73

D-14193 Berlin

[email protected]

Tel: +49 (0)30 897308660

About the company WINDSOR AG:

The company WINDSOR AG, founded in 1993 is an Entry Standard (Open Market)

listed holding company with registered office in Berlin.

The equity holdings of the company WINDSOR AG are active in the pharmaceutical and real estate areas.

End of Corporate News


09.05.2012 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de


168852  09.05.2012

Talk to a Data Expert

Have a question? We'll get back to you promptly.